Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-09-21T17:51:18.595Z.
Calculation as of: 2026-09-21T17:51:18.595Z.
Quote observation: 2026-09-21T17:50:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c3ee83f44a2efdd70b4cb60cd726217b4474c91f0f3ed8ed7c47805bb1a8d1c9
PE RATIO
N/A
Market Cap
$5.10B
PE Ratio
35.29
TTM Avg
37.11
3Y Avg
43.34
5Y Avg
54.41
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.14B | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $488.60M | 85.90 | 37.50 | 27.35 | 28.42 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.90B | N/A | 23.72 | 50.63 | 57.39 |
| Shoulder Innovations, Inc. (SI)vs › | $362.82M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $47.76M | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.05B | 22.89 | 36.33 | 484.90 | 484.90 |
| Doximity, Inc. (DOCS)vs › | $4.99B | 31.41 | 31.54 | 43.68 | 70.84 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 35.29 | 37.11 | 43.34 | 54.41 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.74B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.38B | N/A | 61.77 | 88.64 | 88.64 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$6.25
Forward EPS (Est.)
$-0.86
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
